United Kingdom· GB-APID-7544211000001108
Somavert 20mg powder and solvent for solution for injection vials
A pegvisomant product containing pegvisomant, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Pegvisomant is registered in 14 of 19 countries.
Countries holding a registration under ATC H01AX01 (pegvisomant), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Pegvisomant · ATC H01AX01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of pegvisomant costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pegvisomant · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$81.23
- ES Spain$77.80
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Pegvisomant
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- H01AX01
- ATC class
- Pegvisomant
- Defined daily dose
- 10 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 5
- gtin5415062371565
- gtin5013457027624
- gtin5013457022087
- gtin5013457027631
- gtin5013457022070
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
87 interactions on record for pegvisomant.
Graded by severity as the source publishes them — 87 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pegvisomant · interactions on record
87 records
- 87 moderate
Most severe, free to view
- OpiumA07DA02moderate
- LiraglutidA08AX02moderate
- SemaglutidA08AX03moderate
- Insulin (human)A10AB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pegvisomant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSOMAVERT 20 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEPfizer Europe Ma Eeig
- BelgiumSomavert 20 mgPfizer Europe MA
- IcelandSomavertPfizer Europe MA EEIG*
- NorwaySomavertPfizer Europe MA EEIG (1)
- PolandSomavertPfizer Europe MA EEIG
- SwedenSOMAVERT 20 mg Pulver och vätska till injektionsvätska, lösningPfizer Europe MA EEIG
- CzechiaSOMAVERTPfizer Europe MA EEIG, Bruxelles
- CanadaSOMAVERTPFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Somavert
- Liechtenstein · Somavert
- Norway · Somavert
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5d7d53c-3d09-409a-a5aa-da36e169c1dc GET /v1/drugs/b5d7d53c-3d09-409a-a5aa-da36e169c1dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "7544211000001108",
"desc": "Somavert 20mg powder and solvent for solution for injection vials (Pfizer Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "7544011000001103",
"source": "dmd",
"vtm_id": "777103001",
"strength": "20 mg",
"substance": "Pegvisomant",
"ingredient": "Pegvisomant",
"supplier_code": "2082201000001106"
}See everything about pegvisomant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.